TC BioPharm (Holdings) plc ADR’s Banking’s 100-Day Moving Average at 4.9860: Will the Stock Break Through?

The market performance of TC BioPharm (Holdings) plc ADR has been somewhat unstable. Over the past year, the company’s stock achieved a high of $94.20 on 02/27/23, with the lowest value for the same timeframe being $0.85, recorded on 02/05/24.

52-week price history of TCBP Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. TC BioPharm (Holdings) plc ADR’s current trading price is -98.72% away from its 52-week high, while its distance from the 52-week low is 42.34%. The stock’s price range during this period has fluctuated between $0.85 and $94.20. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.0 million for the day, which was evidently higher than the average daily volume of 0.78 million over the last three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Financial Performance and Market Capitalization

TC BioPharm (Holdings) plc ADR (TCBP) has experienced a quarterly decline of -87.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 0.82M and boasts a workforce of 77 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.9860, with a change in price of -6.5100. Similarly, TC BioPharm (Holdings) plc ADR recorded 503,489 in trading volume during the last 100 days, posting a change of -84.33%.

TCBP Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TCBP stands at 1.16. Similarly, the long-term debt-to-equity ratio is also 0.83.

TCBP Stock Stochastic Average

TC BioPharm (Holdings) plc ADR’s raw stochastic average for the past 50 days is currently at 10.91%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 40.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 32.08% and 26.74%, respectively.

TCBP Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -61.83%.However, over the last six months, we can see a stronger performance of -88.09%. Over the last 30 days, the price of TCBP has leaped by -30.66%. And in the last five days, it has surged by 12.04%.

On Key

Related Posts